Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma

Haematologica. 2024 Nov 7. doi: 10.3324/haematol.2024.285933. Online ahead of print.

Abstract

Not available.